KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Exchange Rate Effect: 2022-2024

Historic Exchange Rate Effect for Recursion Pharmaceuticals (RXRX) over the last 3 years, with Dec 2024 value amounting to -$3.4 million.

  • Recursion Pharmaceuticals' Exchange Rate Effect rose 363.77% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 6471.05%. This contributed to the annual value of -$3.4 million for FY2024, which is 1911.70% down from last year.
  • Recursion Pharmaceuticals' Exchange Rate Effect amounted to -$3.4 million in FY2024, which was down 1,911.70% from $188,000 recorded in FY2023.
  • Recursion Pharmaceuticals' 5-year Exchange Rate Effect high stood at $188,000 for FY2023, and its period low was -$3.4 million during FY2024.
  • Over the past 3 years, Recursion Pharmaceuticals' median Exchange Rate Effect value was -$307,000 (recorded in 2022), while the average stood at -$1.2 million.
  • As far as peak fluctuations go, Recursion Pharmaceuticals' Exchange Rate Effect soared by 161.24% in 2023, and later tumbled by 1,911.70% in 2024.
  • Yearly analysis of 3 years shows Recursion Pharmaceuticals' Exchange Rate Effect stood at -$307,000 in 2022, then spiked by 161.24% to $188,000 in 2023, then plummeted by 1,911.70% to -$3.4 million in 2024.